Proof-point cadence: the last promised marker just landed, and the next one is already on the clock
The model's full reasoning — Q1 2016 call → NO我们根据提供的财报电话会议记录来判断。管理层是否将公司进展呈现为“实时、可核查的证明点序列”,并且同时满足两个条件:(1) 刚刚交付的里程碑;(2) 下一个里程碑已命名且临近。 分析内容: - 关于CUDC-907:管理层提到“we have now completed the enrollment in the monotherapy arm of the Phase 1 and of the total 25 patients in this arm of the study, eight patients have experienced an objective response”。这是刚刚完成的入组,属于具体可验证的步骤。同时,他们提到Phase 2试验正在进行,但未给出具体时间表。他们提到“that study is ongoing”,但没有明确下一个里程碑的具体时间。 - 关于CA170:管理层说“Later this quarter, we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic.” 这是即将发生的具体事件,有明确时间(本季度)。这符合“下一个里程碑已命名且临近”。 - 但第一个条件“刚刚交付的里程碑”是否足够具体?完成Phase 1入组并报告响应率,这算是一个检查点。但管理层是否将其视为“先前描述或承诺的路径上的检查点”?他们提到“we designed our Phase 2 study... that study is ongoing”,但未明确说Phase 1入组完成是之前承诺的。不过,从上下文看,这是他们正在进行的临床试验的一部分,可以视为一个里程碑。 - 然而,对于CUDC-907,他们没有明确说下一个里程碑是什么以及何时。对于CA170,他们给出了进入临床的时间,但那是即将发生的,不是已经完成的。所以,是否同时满足两个条件?第一个条件需要“刚刚完成”的步骤,这里Phase 1入组完成是刚刚完成的。第二个条件需要“下一个具体步骤”并给出时间,CA170进入临床是下一个步骤,时间在本季度。但这两个步骤是否在同一条路径上?CUDC-907和CA170是不同项目,所以不是同一条路径。管理层是否将两者作为同一执行序列?他们分别讨论,但整体上公司有多个项目。问题要求“ONE phenomenon”即一个执行序列。这里似乎没有将两者联系起来作为同一路径。更可能的是,管理层分别报告了不同项目的进展,但没有形成一个连贯的“检查点-下一个检查点”的序列。 再仔细看:对于CUDC-907,他们完成了Phase 1入组,但下一个步骤是Phase 2,他们提到“that study is ongoing”,但没有给出具体时间表。对于CA170,他们即将进入临床,但那是尚未发生的。所以,没有同时满足“刚刚完成”和“下一个临近”在同一路径上。 另外,管理层是否将进展呈现为“实时可核查的序列”?他们报告了数据,但似乎没有强调“我们刚刚完成了这个,接下来我们将做那个”的连贯叙事。他们更多是分别更新。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | Q3 2023 | 2023-11-04 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HIW | Highwoods Properties, Inc. | Q4 2022 | 2023-02-08 | B |
| TCBI | Texas Capital Bancshares, Inc. | Q2 2021 | 2021-07-21 | F |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| CLMT | Calumet Specialty Products Partners, L.P | Q1 2018 | 2018-05-16 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| SCVL | Shoe Carnival, Inc. | Q4 2017 | 2018-03-27 | C+ |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| ITCI | Intra-Cellular Therapies, Inc. | Q4 2017 | 2018-03-01 | D |
| INSM | Insmed Incorporated | Q4 2017 | 2018-02-23 | B |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
XOM · Q2 2018 → YESThe question is whether management presents the company's progress as a LIVE, CHECKABLE SEQUENCE OF PROOF POINTS with both a marker just delivered and the next marker named and near. YES Management presents a live, checkable sequence of proof points. In Neil Chapman's remarks, he explicitly notes that the Coral Floating LNG project is "progressing on schedule" and that "fabrication of the hull is expected to start in the third quarter of this year" — a concrete, near-term operational checkpoint 3–4 months away. Immediately prior, he states that "earlier this month, we announced that the development plan for the first phase has been submitted," treating that submission as the just-completed marker on the same path. He anchors the next step as "targeting final investment decision in 2019" with 2024 first LNG, presented as scheduled and already in motion rather than aspirational. This forms one coherent posture: the company is executing a verifiable execution sequence on the Mozambique LNG opportunity, with the development-plan submission just cleared and FID locked for 2019. Other examples (Baytown ethane cracker operations begun yesterday; 50 new Permian wells brought to sales in the quarter) exist, but the Mozambique LNG thread satisfies both required elements on a single forward path. No other elements (financial beats, routine maintenance, or analyst questions) are used to construct the sequence.
MKC · Q2 2018 → YESThe question is whether management presents the company's progress as a LIVE, CHECKABLE SEQUENCE OF PROOF POINTS with both a marker just delivered and the next marker named and near. YES The transcript shows management framing the Frank's and French's integration as a completed checkpoint ("With the acquisition and integration complete"), then immediately naming and anchoring the next concrete steps on the same path — such as launching the first dedicated mustard campaign in the U.S. (kicked off this week during the call) and 2018 U.S. national TV advertising for Frank's in the second half — as scheduled, in-motion activities that will drive further growth. This is presented as one coherent execution sequence rather than isolated results. Other elements like distribution gains and summer grilling promotions are tied directly to this progression. No routine or vague items qualify; 2018 advertising and marketing acceleration are explicitly tied to the post-integration trajectory.
CMPS · Q3 2023 → YESThe question is whether management presents the company's progress as a LIVE, CHECKABLE SEQUENCE OF PROOF POINTS with both a marker just delivered and the next marker named and near. YES The transcript shows management framing progress as a live execution sequence: the open-label PTSD Phase II study has just reached full recruitment (a concrete checkpoint passed), and they explicitly name the next marker — top-line readout this year — as the immediate follow-on step already in motion and scheduled within the coming months. This is presented as part of the same forward trajectory they are tracking, alongside the TRD Phase III where site initiations (3/4 of COMP005) are described as continuing to advance toward the summer 2024 readout.